New analogues of AHMA as potential antitumor agents: synthesis and biological activity. 2003

Jang-Yang Chang, and Chyun-Feng Lin, and Wen-Yu Pan, and Valeriy Bacherikov, and Ting-Chao Chou, and Ching-Huang Chen, and Huajin Dong, and Shu-Yun Cheng, and Tsong-Jen Tasi, and Yi-Wen Lin, and Kuo-Tung Chen, and Li-Tzong Chen, and Tsann-Long Su
Division of Cancer Research, National Health Research Institutes, Taipei, Taiwan.

A series of new analogues of 3-(9-acridinylamino)-5-hydroxymethylaniline (AHMA, 1) and AHMA-ethylcarbamate (2) were synthesized by introducing an O-alkylcarboxylic acid esters to the CH(2)OH function, displacing the CH(2)OH function with a dimethylaminocarboxamido group or with a methyl function introduced at the meta-, para- or ortho-position to the NH(2) group to form 5-(9-acridinylamino)-m-toluidines (AMTs), 5-(9-acridinylamino)-p-toluidines (APTs) or 5-(9-acridinylamino)-o-toluidines (AOTs), respectively. The inhibitions of a variety of human tumor cell growth, interactions with DNA as well as inhibitory effect against topoisomerase II (Topo II) of these new agents were studied. Among AMT, APT and AOT derivatives with dimethylaminoethylcarboxamido and Me at C4 and C5 of acridine moiety (i.e., 21c, 23c and 26c) were more cytotoxic than AHMA (1) and AHMA-ethylcarbamate (2), depending upon the tumor cell line tested. Detailed structure-activity relationships of the new analogues were studied.

UI MeSH Term Description Entries
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000166 Acridines Compounds that include the structure of acridine. Acridine
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Jang-Yang Chang, and Chyun-Feng Lin, and Wen-Yu Pan, and Valeriy Bacherikov, and Ting-Chao Chou, and Ching-Huang Chen, and Huajin Dong, and Shu-Yun Cheng, and Tsong-Jen Tasi, and Yi-Wen Lin, and Kuo-Tung Chen, and Li-Tzong Chen, and Tsann-Long Su
September 2002, Journal of medicinal chemistry,
Jang-Yang Chang, and Chyun-Feng Lin, and Wen-Yu Pan, and Valeriy Bacherikov, and Ting-Chao Chou, and Ching-Huang Chen, and Huajin Dong, and Shu-Yun Cheng, and Tsong-Jen Tasi, and Yi-Wen Lin, and Kuo-Tung Chen, and Li-Tzong Chen, and Tsann-Long Su
January 2014, Medicinal chemistry (Shariqah (United Arab Emirates)),
Jang-Yang Chang, and Chyun-Feng Lin, and Wen-Yu Pan, and Valeriy Bacherikov, and Ting-Chao Chou, and Ching-Huang Chen, and Huajin Dong, and Shu-Yun Cheng, and Tsong-Jen Tasi, and Yi-Wen Lin, and Kuo-Tung Chen, and Li-Tzong Chen, and Tsann-Long Su
January 2015, European journal of medicinal chemistry,
Jang-Yang Chang, and Chyun-Feng Lin, and Wen-Yu Pan, and Valeriy Bacherikov, and Ting-Chao Chou, and Ching-Huang Chen, and Huajin Dong, and Shu-Yun Cheng, and Tsong-Jen Tasi, and Yi-Wen Lin, and Kuo-Tung Chen, and Li-Tzong Chen, and Tsann-Long Su
April 1992, Journal of medicinal chemistry,
Jang-Yang Chang, and Chyun-Feng Lin, and Wen-Yu Pan, and Valeriy Bacherikov, and Ting-Chao Chou, and Ching-Huang Chen, and Huajin Dong, and Shu-Yun Cheng, and Tsong-Jen Tasi, and Yi-Wen Lin, and Kuo-Tung Chen, and Li-Tzong Chen, and Tsann-Long Su
May 1980, Journal of medicinal chemistry,
Jang-Yang Chang, and Chyun-Feng Lin, and Wen-Yu Pan, and Valeriy Bacherikov, and Ting-Chao Chou, and Ching-Huang Chen, and Huajin Dong, and Shu-Yun Cheng, and Tsong-Jen Tasi, and Yi-Wen Lin, and Kuo-Tung Chen, and Li-Tzong Chen, and Tsann-Long Su
February 2016, European journal of medicinal chemistry,
Jang-Yang Chang, and Chyun-Feng Lin, and Wen-Yu Pan, and Valeriy Bacherikov, and Ting-Chao Chou, and Ching-Huang Chen, and Huajin Dong, and Shu-Yun Cheng, and Tsong-Jen Tasi, and Yi-Wen Lin, and Kuo-Tung Chen, and Li-Tzong Chen, and Tsann-Long Su
July 1983, Journal of pharmaceutical sciences,
Jang-Yang Chang, and Chyun-Feng Lin, and Wen-Yu Pan, and Valeriy Bacherikov, and Ting-Chao Chou, and Ching-Huang Chen, and Huajin Dong, and Shu-Yun Cheng, and Tsong-Jen Tasi, and Yi-Wen Lin, and Kuo-Tung Chen, and Li-Tzong Chen, and Tsann-Long Su
June 2006, Journal of medicinal chemistry,
Jang-Yang Chang, and Chyun-Feng Lin, and Wen-Yu Pan, and Valeriy Bacherikov, and Ting-Chao Chou, and Ching-Huang Chen, and Huajin Dong, and Shu-Yun Cheng, and Tsong-Jen Tasi, and Yi-Wen Lin, and Kuo-Tung Chen, and Li-Tzong Chen, and Tsann-Long Su
April 2021, Bioorganic & medicinal chemistry,
Jang-Yang Chang, and Chyun-Feng Lin, and Wen-Yu Pan, and Valeriy Bacherikov, and Ting-Chao Chou, and Ching-Huang Chen, and Huajin Dong, and Shu-Yun Cheng, and Tsong-Jen Tasi, and Yi-Wen Lin, and Kuo-Tung Chen, and Li-Tzong Chen, and Tsann-Long Su
September 2019, European journal of medicinal chemistry,
Copied contents to your clipboard!